A Biomarker Identification Trial of Tarceva (Erlotinib) in Patients With Advanced Pancreatic Cancer
Clinical trial NCT00674973 · COMPLETED
Trial details
- NCT number
- NCT00674973
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-06-01
- Primary completion
- 2010-12-01
- Enrollment
- 207
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.